ey0015.13-13 | Type 1 and Type 2 Diabetes in Resource-Limited Settings | ESPEYB15
ME Robinson , K Altenor , C Carpenter , R Bonnell , E Jean-Baptiste , J von Oettingen
ey0015.13-14 | Type 1 and Type 2 Diabetes in Resource-Limited Settings | ESPEYB15
E Wheeler , A Leong , CT Liu , MF Hievert , R Strawbridge , C Podmore
ey0020.4-13 | Effects of Hormone Intervention on the Immune System | ESPEYB20
GA Robinson , J Peng , H Peckham , G Butler , I Pineda-Torra , C Ciurtin , EC Jury
ey0020.5-5 | Clinical Guidance and Studies | ESPEYB20
CP Hagen , MB Fischer , C Wohlfahrt-Veje , M Assens , AS Busch , AT Pedersen , A Juul , KM Main
ey0020.7-9 | Bone Health in Inflammatory Bowel Disease | ESPEYB20
GV Sigurdsson , S Schmidt , D Mellstrom , C Ohlsson , R Saalman , M Lorentzon
ey0020.8-17 | New Genetic Approaches | ESPEYB20
A Iakovliev , SJ McGurnaghan , C Hayward , M Colombo , D Lipschutz , A Spiliopoulou , HM Colhoun , PM McKeigue
ey0021.1-1 | New Mechanisms | ESPEYB21
Lettieri A. , Oleari R. , van den Munkhof M.H. , van Battum E.Y. , Verhagen M.G. , Tacconi C.
ey0021.1-5 | Novel Genes | ESPEYB21
Scagliotti V. , Vignola M.L. , Willis T. , Howard M. , Marinelli E. , Gaston-Massuet C.
ey0021.4-4 | Important for Clinical Practice | ESPEYB21
G Muthuvel , SS Al Remeithi , C Foley , A Dauber , V Hwa , P Backeljauw
ey0021.7-11 | Basic Research | ESPEYB21
Miera C Saenz de , N Bellefontaine , SJ Allen , MG Myers , CF Elias